Sociodemographic features predict antidepressant trajectories of response in diverse antidepressant pharmacotreatment environments: a comparison between the STAR*D study and an independent trial

Antonio Drago, Alessandro Serretti

Research output: Contribution to journalJournal articleResearchpeer-review

10 Citations (Scopus)

Abstract

There is consistent evidence that sociodemographic variables modulate antidepressant response. How the magnitude of such association behaves in different samples and different environments has been poorly investigated. We validated a set of known sociodemographic predictors for trajectories of antidepressant response in both the sequenced treatment alternatives to relieve depression and in an Italian sample. The odds ratios for response were 2.6 and 2.2 (American and Italian, respectively; P = 0.0005 and P = 0.002) for a combination of sociodemographic variables in both groups. This was surprising in that American patients were treated in a variety of specialized or not specialized units widespread in their country, whereas the Italian patients were all inpatients treated in a structure specialized in mood disorders. Thus, we suggest that the environment in which a depressed patient is treated does not significantly affect the association between sociodemographic predictors and response to the pharmacological antidepressant treatment.

Original languageEnglish
JournalJournal of Clinical Psychopharmacology
Volume31
Issue number3
Pages (from-to)345-8
Number of pages4
ISSN0271-0749
DOIs
Publication statusPublished - Jun 2011
Externally publishedYes

Keywords

  • Adult
  • Antidepressive Agents/therapeutic use
  • Cross-Cultural Comparison
  • Demography/statistics & numerical data
  • Depressive Disorder, Major/diagnosis
  • Environment
  • Female
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Models, Statistical
  • Severity of Illness Index
  • United States

Fingerprint

Dive into the research topics of 'Sociodemographic features predict antidepressant trajectories of response in diverse antidepressant pharmacotreatment environments: a comparison between the STAR*D study and an independent trial'. Together they form a unique fingerprint.

Cite this